DOI 10.1080/15257770.2026.2710129
LncRNA APTR as a potential prognostic biomarker for triple-negative breast cancer.
Аннотация
Triple-negative breast cancer (TNBC) is the most invasive subtype of breast cancer (BC) with high recurrence, high mortality, poor prognosis, and a lack of effective targeted therapies. This study aimed to investigate the prognostic value of lncRNA Alu-mediated p21 transcriptional regulator (APTR) in TNBC. APTR/miR-298 levels in TNBC tissues and cell lines were detected by RT-qPCR. The correlation between APTR and the prognosis of TNBC patients was analyzed by Kaplan-Meier survival analysis. The direct binding relationship between APTR and miR-298 was verified with a luciferase reporter assay. CCK-8 and Transwell assays were conducted to elucidate the role of APTR knockdown and miR-298 co-knockdown in regulating the viability and migration of TNBC cells. APTR was upregulated in TNBC tissues and cell lines, while miR-298 was downregulated. High APTR expression was closed associated with poor prognosis of TNBC patients. Mechanistically, APTR directly binds to and negatively regulates miR-298. Functional experiments showed that knockdown of APTR significantly inhibited the viability and migration of TNBC cells, while miR-298 inhibition partially abrogated these tumor-suppressive effects. APTR is upregulated in TNBC and is closely related to poor prognosis. APTR exerts an oncogenic role in TNBC by negatively regulating miR-298, suggesting that APTR serves as a promising novel prognostic biomarker for TNBC.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.